Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Assessment of New Radiation Oncology Technologies and Treatments (ANROTAT) TROG Research Project TRP11.A

NCT01379872 is registered in ClinicalTrials.gov with Trans Tasman Radiation Oncology Group as lead sponsor.

NCT NCT01379872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01379872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Assessment of New Radiation Oncology Technologies and Treatments (ANROTAT) TROG Research Project TRP11.A
Lead sponsor
Trans Tasman Radiation Oncology Group
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
June 30, 2012
Enrollment
138 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

anal cancer, intermediate risk prostate cancer, nasopharyngeal cancer, prostate cancer (post prostatectomy)